Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Xi Wang
    Senior Member
    • Oct 2009
    • 317

    #1

    RNA-seq cDNA preparation

    In Mortazavi et al's paper entitled with "Mapping and quantifying mammalian transcriptomes by RNA-Seq", it was described that:

    The mRNA was first fragmented by addition of 5× fragmentation buffer (200
    mM Tris acetate, pH 8.2, 500 mM potassium acetate and 150 mM
    magnesium acetate) and heating at 94 °C for 2 min 30 s in a thermocycler
    and was then transferred to ice and run over a Sephadex-
    G50 column (USA Scientific) to remove the fragmentation ions.
    The reason for using random priming rather than dT priming is
    that the latter typically produces a bias in the product that favors
    3′ end representation. The extension issues do not affect all transcripts
    identically, and the cDNA population that results for each RNA species
    is a complex function of its specific properties as a substrate for
    reverse transcription and the overall transcript length. We used 3 μg
    random hexamers, added to prime first-strand reverse transcription
    according to the manufacturer’s protocol (Invitrogen cDNA synthesis
    kit). After the first strand was synthesized, a custom secondstrand
    synthesis buffer (Illumina) was added, and dNTPs, RNase H
    and Escherichia coli polymerase I were added to nick translate the
    second-strand synthesis for 2.5 h at 16 °C. The reaction was then
    cleaned up on a QiaQuick PCR column (Qiagen) and eluted in 30 μl
    EB buffer (Qiagen).
    I am just wondering the cDNA preparation method is followed by the protocol provided by Illumina? Thanks in advance!
    Xi Wang

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...